116 related articles for article (PubMed ID: 32246519)
1. Biological behaviour and ezrin expression in canine rhabdomyosarcomas: 25 cases (1990-2012).
Connell DR; Rodriguez CO; Sternberg RA; Singh K; Barger A; Garrett LD
Vet Comp Oncol; 2020 Dec; 18(4):675-682. PubMed ID: 32246519
[TBL] [Abstract][Full Text] [Related]
2. Ezrin and moesin expression in canine and feline osteosarcoma.
Hlavaty J; Wolfesberger B; Hauck M; Obermayer-Pietsch B; Fuchs-Baumgartinger A; Miller I; Walter I
Histol Histopathol; 2017 Aug; 32(8):805-816. PubMed ID: 27900754
[TBL] [Abstract][Full Text] [Related]
3. Effects of transplantation sites on tumour growth, pulmonary metastasis and ezrin expression of canine osteosarcoma cell lines in nude mice.
Jaroensong T; Endo Y; Lee SJ; Kamida A; Mochizuki M; Nishimura R; Sasaki N; Nakagawa T
Vet Comp Oncol; 2012 Dec; 10(4):274-82. PubMed ID: 22236104
[TBL] [Abstract][Full Text] [Related]
4. Desmin as a marker for canine botryoid rhabdomyosarcomas.
Andreasen CB; White MR; Swayne DE; Graves GN
J Comp Pathol; 1988 Jan; 98(1):23-9. PubMed ID: 3346389
[TBL] [Abstract][Full Text] [Related]
5. Protein kinase C regulates ezrin-radixin-moesin phosphorylation in canine osteosarcoma cells.
Hong SH; Osborne T; Ren L; Briggs J; Mazcko C; Burkett SS; Khanna C
Vet Comp Oncol; 2011 Sep; 9(3):207-18. PubMed ID: 21848623
[TBL] [Abstract][Full Text] [Related]
6. A comparative review of canine and human rhabdomyosarcoma with emphasis on classification and pathogenesis.
Caserto BG
Vet Pathol; 2013 Sep; 50(5):806-26. PubMed ID: 23439712
[TBL] [Abstract][Full Text] [Related]
7. Expression of myogenic regulating factors, Myogenin and MyoD, in two canine botryoid rhabdomyosarcomas.
Kobayashi M; Sakai H; Hirata A; Yonemaru K; Yanai T; Watanabe K; Yamazoe K; Kudo T; Masegi T
Vet Pathol; 2004 May; 41(3):275-7. PubMed ID: 15133178
[TBL] [Abstract][Full Text] [Related]
8. Role of ezrin in osteosarcoma metastasis.
Ren L; Khanna C
Adv Exp Med Biol; 2014; 804():181-201. PubMed ID: 24924175
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of Myogenin and MyoD1 as Immunohistochemical Markers of Canine Rhabdomyosarcoma.
Tuohy JL; Byer BJ; Royer S; Keller C; Nagai-Singer MA; Regan DP; Seguin B
Vet Pathol; 2021 May; 58(3):516-526. PubMed ID: 33691532
[TBL] [Abstract][Full Text] [Related]
10. Canine orbital rhabdomyosarcoma: a report of 18 cases.
Scott EM; Teixeira LB; Flanders DJ; Dubielzig RR; McLellan GJ
Vet Ophthalmol; 2016 Mar; 19(2):130-7. PubMed ID: 25846977
[TBL] [Abstract][Full Text] [Related]
11. Multifocal rhabdomyosarcomas within the tongue and oral cavity of a dog.
Brockus CW; Myers RK
Vet Pathol; 2004 May; 41(3):273-4. PubMed ID: 15133177
[TBL] [Abstract][Full Text] [Related]
12. Biological behaviour of canine mandibular osteosarcoma. A retrospective study of 50 cases (1999-2007).
Coyle VJ; Rassnick KM; Borst LB; Rodriguez CO; Northrup NC; Fan TM; Garrett LD
Vet Comp Oncol; 2015 Jun; 13(2):89-97. PubMed ID: 23410097
[TBL] [Abstract][Full Text] [Related]
13. Prognostic significance of immunohistochemical expression of ezrin in non-metastatic high-grade osteosarcoma.
Ferrari S; Zanella L; Alberghini M; Palmerini E; Staals E; Bacchini P
Pediatr Blood Cancer; 2008 Apr; 50(4):752-6. PubMed ID: 17886294
[TBL] [Abstract][Full Text] [Related]
14. Ezrin expression in rectal cancer predicts time to development of local recurrence.
Jörgren F; Nilbert M; Rambech E; Bendahl PO; Lindmark G
Int J Colorectal Dis; 2012 Jul; 27(7):893-9. PubMed ID: 22234584
[TBL] [Abstract][Full Text] [Related]
15. Intravital imaging reveals systemic ezrin inhibition impedes cancer cell migration and lymph node metastasis in breast cancer.
Ghaffari A; Hoskin V; Turashvili G; Varma S; Mewburn J; Mullins G; Greer PA; Kiefer F; Day AG; Madarnas Y; SenGupta S; Elliott BE
Breast Cancer Res; 2019 Jan; 21(1):12. PubMed ID: 30678714
[TBL] [Abstract][Full Text] [Related]
16. Ezrin and alpha-smooth muscle actin are immunohistochemical prognostic markers in conventional osteosarcomas.
Salas S; Bartoli C; Deville JL; Gaudart J; Fina F; Calisti A; Bollini G; Curvale G; Gentet JC; Duffaud F; Figarella-Branger D; Bouvier C
Virchows Arch; 2007 Dec; 451(6):999-1007. PubMed ID: 17786474
[TBL] [Abstract][Full Text] [Related]
17. Immunohistochemical evaluation of canine peripheral nerve sheath tumors and other soft tissue sarcomas.
Chijiwa K; Uchida K; Tateyama S
Vet Pathol; 2004 Jul; 41(4):307-18. PubMed ID: 15232130
[TBL] [Abstract][Full Text] [Related]
18. Clinical outcome in 20 cases of lingual hemangiosarcoma in dogs: 1996-2011.
Burton JH; Powers BE; Biller BJ
Vet Comp Oncol; 2014 Sep; 12(3):198-204. PubMed ID: 22905712
[TBL] [Abstract][Full Text] [Related]
19. Ezrin expression predicts local recurrence and development of metastases in soft tissue sarcomas.
Carneiro A; Bendahl PO; Åkerman M; Domanski HA; Rydholm A; Engellau J; Nilbert M
J Clin Pathol; 2011 Aug; 64(8):689-94. PubMed ID: 21653656
[TBL] [Abstract][Full Text] [Related]
20. Urinary bladder botryoid rhabdomyosarcoma with widespread metastases in an 8-month-old Labrador cross dog.
Gerber K; Rees P
J S Afr Vet Assoc; 2009 Sep; 80(3):199-203. PubMed ID: 20169756
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
